That the Indian pharmaceutical industry is going through a difficult period is an undisputed fact, thanks mainly to the unprecedented quality issues being raised by the US FDA. For the last couple of years, the Indian pharmaceutical companies, especially those which have exposure to regulated markets ...
Read more: TOP COS IN TROUBLE